← Back to Search

Nighttime Feminine Product for Heavy Menstrual Bleeding

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial evaluates how menstrual products & sleep behaviors affect sleep during 3 menstrual cycles for women with heavy bleeding.

Who is the study for?
This trial is for women aged 18-50 with heavy menstrual bleeding who use pads at night and often wake up or take measures to prevent leakage. They must have regular menstrual cycles, an intact uterus, one ovary, and be generally healthy without significant diseases. Night-shift workers or those planning pregnancy are excluded.Check my eligibility
What is being tested?
The study tests how a standardized nighttime feminine product affects sleep during menstruation over three cycles. The first cycle is observed as a baseline; the second involves using the product, and the third adds behavioral changes to avoid leaks.See study design
What are the potential side effects?
There may not be direct side effects from using the nighttime feminine products themselves; however, participants might experience discomfort or disruption in their usual sleep patterns due to adherence to new behaviors required by the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Pittsburgh Sleep Quality Index (PSQI)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Women with reported heavy mensesExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,601 Previous Clinical Trials
915,634 Total Patients Enrolled

Media Library

Women with reported heavy menses Clinical Trial Eligibility Overview. Trial Name: NCT05722444 — N/A
Heavy Menstruation Research Study Groups: Women with reported heavy menses
Heavy Menstruation Clinical Trial 2023: Women with reported heavy menses Highlights & Side Effects. Trial Name: NCT05722444 — N/A
Women with reported heavy menses 2023 Treatment Timeline for Medical Study. Trial Name: NCT05722444 — N/A
~11 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top